Fidelity Investments’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36K | Sell |
1,025
-1,753
| -63% | -$2.33K | ﹤0.01% | 4917 |
|
|
2025
Q1 | $3.31K | Buy |
2,778
+1,931
| +228% | +$2.3K | ﹤0.01% | 4799 |
|
|
2024
Q4 | $1.38K | Sell |
847
-1,362
| -62% | -$2.22K | ﹤0.01% | 4877 |
|
|
2024
Q3 | $8.44K | Sell |
2,209
-223
| -9% | -$852 | ﹤0.01% | 4475 |
|
|
2024
Q2 | $7.13K | Buy |
2,432
+1,068
| +78% | +$3.13K | ﹤0.01% | 4435 |
|
|
2024
Q1 | $5.4K | Sell |
1,364
-931
| -41% | -$3.69K | ﹤0.01% | 4475 |
|
|
2023
Q4 | $11.4K | Buy |
2,295
+779
| +51% | +$3.87K | ﹤0.01% | 4197 |
|
|
2023
Q3 | $7.65K | Sell |
1,516
-362
| -19% | -$1.83K | ﹤0.01% | 4206 |
|
|
2023
Q2 | $9.45K | Buy |
1,878
+1,863
| +12,420% | +$9.37K | ﹤0.01% | 4163 |
|
|
2023
Q1 | $92 | Sell |
15
-2
| -12% | -$12 | ﹤0.01% | 4911 |
|
|
2022
Q4 | $224 | Buy |
+17
| New | +$224 | ﹤0.01% | 4814 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | – | – | 4854 |
|
|
2021
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4709 |
|
|
2018
Q1 | – | Sell |
-2,441
| Closed | -$457K | – | 2722 |
|
|
2017
Q4 | $457K | Hold |
2,441
| – | – | ﹤0.01% | 2536 |
|
|
2017
Q3 | $524K | Sell |
2,441
-60
| -2% | -$12.9K | ﹤0.01% | 2475 |
|
|
2017
Q2 | $513K | Sell |
2,501
-83
| -3% | -$17K | ﹤0.01% | 2504 |
|
|
2017
Q1 | $471K | Sell |
2,584
-7,870
| -75% | -$1.43M | ﹤0.01% | 2538 |
|
|
2016
Q4 | $2.61M | Hold |
10,454
| – | – | ﹤0.01% | 2327 |
|
|
2016
Q3 | $2.18M | Hold |
10,454
| – | – | ﹤0.01% | 2352 |
|
|
2016
Q2 | $2.11M | Sell |
10,454
-46,235
| -82% | -$9.35M | ﹤0.01% | 2374 |
|
|
2016
Q1 | $10.4M | Sell |
56,689
-88,446
| -61% | -$16.2M | ﹤0.01% | 1945 |
|
|
2015
Q4 | $36.3M | Buy |
+145,135
| New | +$36.3M | ﹤0.01% | 1391 |
|